Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-10 Sale |
2022-11-14 9:00 pm |
Zymeworks BC Inc. | ZYME | Josephson Neil Chief Medical Officer |
2,475 | $8.099 | $20,045 | 26,221 (Direct) |
View |
| 2022-03-10 Sale |
2022-03-11 9:00 pm |
Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer |
2,979 | $6.88 | $20,496 | 221,893 (Indirect Direct) |
View |
| 2022-01-07 Purchase |
2022-01-11 9:47 pm |
Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer |
5,000 | $14.28 | $71,386 | 7,119 (Direct) |
View |
| 2021-07-15 Sale |
2021-07-16 9:30 pm |
Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer |
44,991 | $36 | $1,619,676 | 357,027 (Indirect Direct) |
View |
| 2021-07-12 Sale |
2021-07-13 8:00 pm |
Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer |
12,669 | $36.12 | $457,635 | 360,827 (Indirect Direct) |
View |
| 2021-04-13 Sale |
2021-04-13 9:30 pm |
Zymeworks Inc. | ZYME | Priour James Chief Commercial Officer |
950 | $27.93 | $26,533 | 6,537 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 8:00 pm |
Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer |
786 | $34.72 | $27,290 | 100,000 (Direct) |
View |
| 2021-03-10 Sale |
2021-03-12 8:00 pm |
Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer |
568 | $34.95 | $19,854 | 43,498 (Direct) |
View |
| 2021-03-10 Sale |
2021-03-12 8:00 pm |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
1,048 | $34.95 | $36,631 | 92,854 (Direct) |
View |
| 2021-03-10 Sale |
2021-03-12 8:00 pm |
Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer |
4,392 | $34.95 | $153,516 | 506,253 (Indirect Direct) |
View |
| 2021-03-10 Sale |
2021-03-12 8:00 pm |
Zymeworks Inc. | ZYME | HAUSMAN DIANA Chief Medical Officer |
1,048 | $34.95 | $36,631 | 69,252 (Indirect Direct) |
View |
| 2021-03-10 Sale |
2021-03-12 8:00 pm |
Zymeworks Inc. | ZYME | Klompas Neil A Chief Financial Officer |
1,425 | $34.95 | $49,809 | 73,046 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-11-10 Exercise |
2022-11-14 9:00 pm |
N/A N/A |
Zymeworks BC Inc. | ZYME | Josephson Neil Chief Medical Officer |
5,885 | $0 | 26,221 (Direct) |
View |
| 2022-07-18 Option Award |
2022-07-19 9:05 pm |
N/A 2032-07-17 |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-05 9:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer |
1,525 | $4.51 | 11,039 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-05 9:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer |
1,525 | $4.51 | 15,501 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-11 9:00 pm |
N/A 2032-03-09 |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-11 9:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer |
5,208 | $0 | 221,893 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-11 9:00 pm |
N/A 2032-03-09 |
Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer |
200,000 | $0 | 221,893 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-11 9:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer |
2,395 | $0 | 13,578 (Direct) |
View |
Ownership |
2022-03-04 9:20 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
0 | $0 | 21,020 (Direct) |
View |
| 2022-01-15 Option Award |
2022-01-18 06:25 am |
N/A 2032-01-14 |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair, President & CEO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:30 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer |
65 | $13.94 | 2,119 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:30 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
74 | $13.94 | 36,407 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:30 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer & CFO |
277 | $13.94 | 11,747 (Direct) |
View |
| 2021-11-10 Option Award |
2021-11-12 9:00 pm |
N/A 2031-11-09 |
Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer |
123,600 | $0 | 123,600 (Direct) |
View |
| 2021-08-31 Exercise |
2021-09-02 8:00 pm |
N/A 2028-12-11 |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
4,900 | $0 | 113,933 (Direct) |
View |
| 2021-08-31 Exercise |
2021-09-02 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
4,900 | $15 | 113,933 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-16 9:30 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer |
3,800 | $4.2713 | 357,027 (Direct) |
View |
| 2021-07-16 Exercise |
2021-07-16 9:30 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer |
41,191 | $4.2643 | 357,027 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-16 9:30 pm |
2013-01-01 2022-01-01 |
Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer |
44,991 | $0 | 357,027 (Direct) |
View |
| 2021-07-12 Exercise |
2021-07-13 8:00 pm |
2013-01-01 2022-01-01 |
Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer |
12,669 | $0 | 360,827 (Direct) |
View |
| 2021-07-12 Exercise |
2021-07-13 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer |
12,669 | $4.3062 | 360,827 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 8:05 pm |
N/A N/A |
Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer |
510 | $29.49 | 6,350 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
454 | $29.49 | 31,433 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Klompas Neil A Chief Financial Officer |
299 | $29.49 | 11,470 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Priour James Chief Commercial Officer |
510 | $29.49 | 2,513 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Josephson Neil Interim Chief Medical Officer |
461 | $29.49 | 2,054 (Direct) |
View |
Ownership |
2021-05-25 9:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Josephson Neil Interim Chief Medical Officer |
0 | $0 | 146,177 (Direct) |
View |
| 2021-05-06 Option Award |
2021-05-07 8:45 pm |
N/A 2031-05-05 |
Zymeworks Inc. | ZYME | Neu Kelvin Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2021-05-06 Option Award |
2021-05-07 8:45 pm |
N/A 2031-05-05 |
Zymeworks Inc. | ZYME | Hillan Kenneth J. Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2021-05-06 Option Award |
2021-05-07 8:45 pm |
N/A 2031-05-05 |
Zymeworks Inc. | ZYME | Mahony Susan Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2021-05-06 Option Award |
2021-05-07 8:45 pm |
N/A 2031-05-05 |
Zymeworks Inc. | ZYME | Sacks Natalie Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2021-05-06 Option Award |
2021-05-07 8:45 pm |
N/A 2031-05-05 |
Zymeworks Inc. | ZYME | Cox Troy Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2021-05-06 Option Award |
2021-05-07 8:45 pm |
N/A 2031-05-05 |
Zymeworks Inc. | ZYME | RENTON HOLLINGS Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2021-05-06 Option Award |
2021-05-07 8:45 pm |
N/A 2031-05-05 |
Zymeworks Inc. | ZYME | Zoth Lota S. Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 9:30 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Priour James Chief Commercial Officer |
2,266 | $0 | 6,537 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-17 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer |
837 | $34.24 | 100,000 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-17 8:00 pm |
N/A 2029-11-07 |
Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer |
837 | $0 | 100,000 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer |
1,354 | $0 | 43,498 (Direct) |
View |
| 2021-03-10 Option Award |
2021-03-12 8:00 pm |
N/A 2031-03-09 |
Zymeworks Inc. | ZYME | O'Driscoll Kathryn Chief People Officer |
35,000 | $0 | 43,498 (Direct) |
View |
| 2021-03-10 Option Award |
2021-03-12 8:00 pm |
N/A 2031-03-09 |
Zymeworks Inc. | ZYME | Priour James Chief Commercial Officer |
43,750 | $0 | 43,750 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
2,500 | $0 | 92,854 (Direct) |
View |
| 2021-03-10 Option Award |
2021-03-12 8:00 pm |
N/A 2031-03-09 |
Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer |
56,875 | $0 | 92,854 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer |
7,708 | $0 | 506,253 (Direct) |
View |
| 2021-03-10 Option Award |
2021-03-12 8:00 pm |
N/A 2031-03-09 |
Zymeworks Inc. | ZYME | Tehrani Ali Chief Executive Officer |
175,000 | $0 | 506,253 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | HAUSMAN DIANA Chief Medical Officer |
2,500 | $0 | 69,252 (Direct) |
View |
| 2021-03-10 Option Award |
2021-03-12 8:00 pm |
N/A 2031-03-09 |
Zymeworks Inc. | ZYME | HAUSMAN DIANA Chief Medical Officer |
56,875 | $0 | 69,252 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Klompas Neil A Chief Financial Officer |
2,500 | $0 | 73,046 (Direct) |
View |
| 2021-03-10 Option Award |
2021-03-12 8:00 pm |
N/A 2031-03-09 |
Zymeworks Inc. | ZYME | Klompas Neil A Chief Financial Officer |
56,875 | $0 | 73,046 (Direct) |
View |